Promises and risks of opportunistic screening for cardiovascular disease.

Suppr

超能文献

作者信息

Arbab-Zadeh Armin

机构信息

Department of Medicine, Johns Hopkins University, Baltimore, USA.

出版信息

J Cardiovasc Comput Tomogr. 2024 Jul-Aug;18(4):423. doi: 10.1016/j.jcct.2024.06.008.

DOI:10.1016/j.jcct.2024.06.008

PMID:38950936

Abstract

摘要

相似文献

Promises and risks of opportunistic screening for cardiovascular disease.

J Cardiovasc Comput Tomogr. 2024 Jul-Aug;18(4):423. doi: 10.1016/j.jcct.2024.06.008.

Advanced cardiac imaging, machine learning, and heart age for cardiovascular risk stratification.

Int J Cardiovasc Imaging. 2024 Jul;40(7):1605-1606. doi: 10.1007/s10554-024-03093-z. Epub 2024 Apr 13.

Calcification vs Inflammation: The Modern Toolkit for Cardiovascular Risk Assessment.

JACC Cardiovasc Imaging. 2024 Oct;17(10):1225-1228. doi: 10.1016/j.jcmg.2024.08.006.

CAC Density and Cardiovascular Risk: Is Less Really More?

JACC Cardiovasc Imaging. 2022 Nov;15(11):1941-1943. doi: 10.1016/j.jcmg.2022.08.007. Epub 2022 Oct 19.

Cardiovascular imaging to guide primary prevention.

Heart. 2020 Aug;106(16):1267-1275. doi: 10.1136/heartjnl-2019-316217. Epub 2020 May 25.

Reducing Cardiovascular Risk in Asymptomatic Patients With Diabetes: Can Stress PET Move the Needle?

JACC Cardiovasc Imaging. 2024 Mar;17(3):311-313. doi: 10.1016/j.jcmg.2023.12.005.

Progress in Cardiovascular Imaging.

JACC Cardiovasc Imaging. 2019 Dec;12(12):2589-2610. doi: 10.1016/j.jcmg.2019.11.002.

Cardiovascular biomarkers: added value with an integrated approach?

Circulation. 2007 Jul 3;116(1):3-5. doi: 10.1161/CIRCULATIONAHA.107.707984.

Editor's presentation: Do we really need biomarkers for cardiovascular risk prediction?

Eur J Prev Cardiol. 2020 Apr;27(6):563-565. doi: 10.1177/2047487320917001.

The challenge of cardiovascular risk assessment in Chronic Kidney Disease; is there a role for CTA and FFR?

J Cardiovasc Comput Tomogr. 2022 Sep-Oct;16(5):452-453. doi: 10.1016/j.jcct.2022.05.007. Epub 2022 Jun 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Promises and risks of opportunistic screening for cardiovascular disease.

J Cardiovasc Comput Tomogr. 2024 Jul-Aug;18(4):423. doi: 10.1016/j.jcct.2024.06.008.

Advanced cardiac imaging, machine learning, and heart age for cardiovascular risk stratification.

Int J Cardiovasc Imaging. 2024 Jul;40(7):1605-1606. doi: 10.1007/s10554-024-03093-z. Epub 2024 Apr 13.

Calcification vs Inflammation: The Modern Toolkit for Cardiovascular Risk Assessment.

JACC Cardiovasc Imaging. 2024 Oct;17(10):1225-1228. doi: 10.1016/j.jcmg.2024.08.006.

CAC Density and Cardiovascular Risk: Is Less Really More?

JACC Cardiovasc Imaging. 2022 Nov;15(11):1941-1943. doi: 10.1016/j.jcmg.2022.08.007. Epub 2022 Oct 19.

Cardiovascular imaging to guide primary prevention.

Heart. 2020 Aug;106(16):1267-1275. doi: 10.1136/heartjnl-2019-316217. Epub 2020 May 25.

Reducing Cardiovascular Risk in Asymptomatic Patients With Diabetes: Can Stress PET Move the Needle?

JACC Cardiovasc Imaging. 2024 Mar;17(3):311-313. doi: 10.1016/j.jcmg.2023.12.005.

Progress in Cardiovascular Imaging.

JACC Cardiovasc Imaging. 2019 Dec;12(12):2589-2610. doi: 10.1016/j.jcmg.2019.11.002.

Cardiovascular biomarkers: added value with an integrated approach?

Circulation. 2007 Jul 3;116(1):3-5. doi: 10.1161/CIRCULATIONAHA.107.707984.

Editor's presentation: Do we really need biomarkers for cardiovascular risk prediction?

Eur J Prev Cardiol. 2020 Apr;27(6):563-565. doi: 10.1177/2047487320917001.

The challenge of cardiovascular risk assessment in Chronic Kidney Disease; is there a role for CTA and FFR?

J Cardiovasc Comput Tomogr. 2022 Sep-Oct;16(5):452-453. doi: 10.1016/j.jcct.2022.05.007. Epub 2022 Jun 8.